Skip to content

Persian Medicine Products in Covid-19

The Effect of Persian Medicine Products on the Clinical and Laboratory Symptoms of Patients With or Suspected of Covid-19

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140617018126N2
Enrollment
60
Registered
2020-03-29
Start date
2020-04-03
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19. Covid-19

Interventions

Intervention 1: Intervention group: In the intervention group, in addition to the standard treatment, medicinal herbal products will be prescribed. The drug will be given in two combination forms. One

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Over 18 years old patients hospitalized, with or suspected of COVID-19

Exclusion criteria

Exclusion criteria: Having liver, kidney and heart failure History of immunodeficiency Breastfeeding and pregnancy Hypertension Alcohol or drug addiction A history of allergies to medicinal herbs Patients with transplanted organs Cor Pulmonale Patients History of deep vein thrombosis

Design outcomes

Primary

MeasureTime frame
Oxygen saturation. Timepoint: Clinical examination and Pulse Oximetry before starting medication and regularly during treatment. Method of measurement: Pulse Oximeter.;Respiratory Rate. Timepoint: Clinical examination before starting medication and regularly during treatment. Method of measurement: respiratory Count.

Secondary

MeasureTime frame
C-reactive protein. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test.;Lymphocytes. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test.;White Blood Cells. Timepoint: Intravenous blood testing before starting medication and during treatment. Method of measurement: Intravenous blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHojjat Pourfathi Nematabad

Tabriz University of Medical Sciences

hojjatpourfathi@yahoo.com+98 41 3336 4672

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026